Kamil Majchrzak has been hit with a 13-month suspension on a doping violation.

Majchrzak, who reached a career-high ATP singles ranking of 75 in February 2022, was tested by the ITIA at the Sofia Open in September 2022, the Kinoshita Group Japan Open in October 2022, and the FILA Open Seoul Challenger, also in October 2022. Majchrzak was also tested by the Polish Anti-Doping Agency (POLADA) in November 2022.

Raducanu: "Brutal" Tour Featuring Sharks

The International Tennis Integrity Agency announced analysis of the samples confirmed the presence of Prohibited Substance SARM S-22, metabolites of LGD-4033 and a PPARδ agonist - all non-Specified substances listed in the 2022 World Anti-Doping Agency (WADA) Prohibited List. Adverse Analytical Findings (AAFs) for non-Specified Substances carry a mandatory provisional suspension, and Majchrzak was provisionally suspended on November 30, 2022.

Majchrzak admitted the Anti-Doping Rule Violations, but claimed he did not knowingly ingest Prohibited Substances. Majchrzak submitted that the AAFs were the result of a contaminated supplement, providing evidence in the form of purchase receipts and samples of the supplement from the same batch for testing.



The supplement were sent for analysis by both the Majchrzak and the ITIA, confirming the presence of the same Prohibited Substances found in Majchrzak’s positive tests.

The ITIA accepted that Majchrzak had not knowingly or intentionally ingested the Prohibited Substances, and further mitigating evidence includes the player’s consultation with a dietician about the supplement and its ingredients.

Majchrzak's suspension,which includes his time already served, will end on December 29th, 2023. Until then, he is banned from playing, coaching or even attending any tennis event.

Photo credit: Corinne06/Wikimedia Commons